Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease
Quentin M. Anstee, Devanshi Seth, Christopher P. Day
Gastroenterology (2016) Vol. 150, Iss. 8, pp. 1728-1744.e7
Closed Access | Times Cited: 230

Showing 1-25 of 230 citing articles:

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair M. Younossi, Quentin M. Anstee, M. Marietti, et al.
Nature Reviews Gastroenterology & Hepatology (2017) Vol. 15, Iss. 1, pp. 11-20
Closed Access | Times Cited: 4431
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Rohit Loomba, Scott L. Friedman, Gerald I. Shulman
Cell (2021) Vol. 184, Iss. 10, pp. 2537-2564
Open Access | Times Cited: 1228
From NASH to HCC: current concepts and future challenges
Quentin M. Anstee, Helen L. Reeves, Elena Kotsiliti, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 7, pp. 411-428
Closed Access | Times Cited: 1138
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
Anna Mae Diehl, Christopher P. Day
New England Journal of Medicine (2017) Vol. 377, Iss. 21, pp. 2063-2072
Closed Access | Times Cited: 1088
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
Maurizio Parola, Massimo Pinzani
Molecular Aspects of Medicine (2018) Vol. 65, pp. 37-55
Open Access | Times Cited: 886
Triggering and resolution of inflammation in NASH
Susanne Schuster, Daniel Cabrera, Marco Arrese, et al.
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 6, pp. 349-364
Closed Access | Times Cited: 732
Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies
Norbert Stefan, Hans‐Ulrich Häring, Kenneth Cusi
The Lancet Diabetes & Endocrinology (2018) Vol. 7, Iss. 4, pp. 313-324
Closed Access | Times Cited: 731
Alcoholic Liver Disease: Pathogenesis and Current Management.
Natalia A. Osna, Terrence M. Donohue, Kusum K. Kharbanda
PubMed (2017) Vol. 38, Iss. 2, pp. 147-161
Closed Access | Times Cited: 564
Determinants of fibrosis progression and regression in NASH
Detlef Schuppan, Rambabu Surabattula, Xiaoyu Wang
Journal of Hepatology (2017) Vol. 68, Iss. 2, pp. 238-250
Closed Access | Times Cited: 419
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆
Quentin M. Anstee, Rebecca Darlay, Simon Cockell, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 3, pp. 505-515
Open Access | Times Cited: 375
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis
Zobair M. Younossi, Rohit Loomba, Quentin M. Anstee, et al.
Hepatology (2017) Vol. 68, Iss. 1, pp. 349-360
Open Access | Times Cited: 363
NAFLD as a driver of chronic kidney disease
Christopher D. Byrne, Giovanni Targher
Journal of Hepatology (2020) Vol. 72, Iss. 4, pp. 785-801
Open Access | Times Cited: 345
Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease
Quentin M. Anstee, Alessandro Mantovani, Herbert Tilg, et al.
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 7, pp. 425-439
Closed Access | Times Cited: 256
Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population
Fredrik Åberg, Jaana Helenius‐Hietala, Pauli Puukka, et al.
Hepatology (2017) Vol. 67, Iss. 6, pp. 2141-2149
Closed Access | Times Cited: 220
The gut–liver axis and gut microbiota in health and liver disease
Cynthia L. Hsu, Bernd Schnabl
Nature Reviews Microbiology (2023) Vol. 21, Iss. 11, pp. 719-733
Closed Access | Times Cited: 206
Non-alcoholic fatty liver disease: A patient guideline
Sven Francque, Giulio Marchesini, Achim Kautz, et al.
JHEP Reports (2021) Vol. 3, Iss. 5, pp. 100322-100322
Open Access | Times Cited: 205
Molecular Pathogenesis of NASH
Alessandra Caligiuri, Alessandra Gentilini, Fabio Marra
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 9, pp. 1575-1575
Open Access | Times Cited: 192
Improved Diet Quality Associates With Reduction in Liver Fat, Particularly in Individuals With High Genetic Risk Scores for Nonalcoholic Fatty Liver Disease
Jiantao Ma, Rachel Hennein, Chunyu Liu, et al.
Gastroenterology (2018) Vol. 155, Iss. 1, pp. 107-117
Open Access | Times Cited: 165
Alcohol Metabolizing Enzymes, Microsomal Ethanol Oxidizing System, Cytochrome P450 2E1, Catalase, and Aldehyde Dehydrogenase in Alcohol-Associated Liver Disease
Yanchao Jiang, Ting Zhang, Praveen Kusumanchi, et al.
Biomedicines (2020) Vol. 8, Iss. 3, pp. 50-50
Open Access | Times Cited: 146
Alcohol-Associated Hepatitis
Ramón Bataller, Juan Pablo Arab, Vijay H. Shah
New England Journal of Medicine (2022) Vol. 387, Iss. 26, pp. 2436-2448
Closed Access | Times Cited: 140
Metabolic dysfunction–associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment
Paloma Sangro, Manuel de la Torre‐Aláez, Bruno Sangro, et al.
Journal of Physiology and Biochemistry (2023) Vol. 79, Iss. 4, pp. 869-879
Open Access | Times Cited: 60
Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies
Maurizio Parola, Massimo Pinzani
Molecular Aspects of Medicine (2023) Vol. 95, pp. 101231-101231
Open Access | Times Cited: 57
Metabolic Dysfunction–Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options
Piero Portincasa, Mohamad Khalil, Laura Mahdi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5640-5640
Open Access | Times Cited: 16
Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases
Yao Yu, Jingjing Cai, Zhi‐Gang She, et al.
Advanced Science (2018) Vol. 6, Iss. 4
Open Access | Times Cited: 149
The genetics of alcohol dependence and alcohol-related liver disease
Felix Stickel, Christophe Moreno, Jochen Hampe, et al.
Journal of Hepatology (2016) Vol. 66, Iss. 1, pp. 195-211
Open Access | Times Cited: 148
Page 1 - Next Page

Scroll to top